Novartis AG
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $67.66B | $12.41B |
| FY2022 | — | $59.34B | $7.52B |
| FY2023 | — | $46.67B | $13.39B |
| FY2024 | — | $44.05B | $11.46B |
| FY2025 | — | $46.13B | $11.44B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $67.66B | $12.41B |
| FY2022 | — | $59.34B | $7.52B |
| FY2023 | — | $46.67B | $13.39B |
| FY2024 | — | $44.05B | $11.46B |
| FY2025 | — | $46.13B | $11.44B |